Results 141 to 150 of about 59,326 (211)

Assessment of Placental Extracellular Vesicles-Associated Fas Ligand and TNF-Related Apoptosis-Inducing Ligand in Pregnancies Complicated by Early and Late Onset Preeclampsia. [PDF]

Front Physiol, 2021
Ayala-Ramírez P, Machuca-Acevedo C, Gámez T, Quijano S, Barreto A, Silva JL, Olaya-C M, García-Robles R.   +7 more
europepmc   +1 more source

CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit. [PDF]

Nat Cancer
Yi F, Cohen T, Zimmerman N, Dündar F, Zumbo P, Eltilib R, Brophy EJ, Arkin H, Feucht J, Gormally MV, Hackett CS, Kropp KN, Etxeberria I, Chandran SS, Zhao Z, Cai W, Daniyan AF, Park JH, Lareau CA, Hsu KC, Sadelain M, Betel D, Klebanoff CA.   +22 more
europepmc   +1 more source

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy. [PDF]

Nat Commun
Wamba BEN, Mondal T, Freenor V F, Shaheed M, Pang O, Bedinger D, Legembre P, Devel L, Bhatnagar S, Leiserowitz GS, Tushir-Singh J.   +10 more
europepmc   +1 more source

Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand. [PDF]

Apoptosis
Łasut-Szyszka B, Gdowicz-Kłosok A, Krześniak M, Głowala-Kosińska M, Będzińska A, Rusin M.   +5 more
europepmc   +1 more source

Matrix metalloproteinase/Fas ligand (MMP/FasL) interaction dynamics in COVID-19: An in silico study and neuroimmune perspective. [PDF]

Heliyon
Saleki K, Aram C, Alijanizadeh P, Khanmirzaei MH, Vaziri Z, Ramzankhah M, Azadmehr A.   +6 more
europepmc   +1 more source

Prognostic Value of Fas/Fas Ligand Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Patients with Metastatic Breast Cancer. [PDF]

Cancers (Basel)
Papadaki MA, Papadaki E, Chatziavraam S, Aggouraki D, Michaelidou K, Fotsitzoudis C, Vassilakopoulou M, Mavroudis D, Agelaki S.   +8 more
europepmc   +1 more source

Fas ligand regulate nerve injury and repair by affecting AKT, β-catenin, and NF-κB pathways. [PDF]

IBRO Neurosci Rep
Zhou Y, Yao Y, Feng Y, Qiu Z, Luo S, Shi X, Gu D, Jiang M, Cai M, Yao D.   +9 more
europepmc   +1 more source

Fas Ligand (FasL) in Association with Tumor-Infiltrating Lymphocytes (TILs) in Early Stage Cervical Cancer. [PDF]

Asian Pac J Cancer Prev, 2020
Anggraeni TD, Rustamadji P, Aziz MF.
europepmc   +1 more source

Corrigendum: Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models. [PDF]

Front Immunol
Lotti R, Hundt JE, Ludwig RJ, Hammers CM, Bennett B, Amato A, Marconi A, Pincelli C.   +7 more
europepmc   +1 more source

Lumican silencing alleviates tumor necrosis factor-α-induced nucleus pulposus cell inflammation and senescence by inhibiting apoptosis signal regulating kinase 1/p38 signaling pathway via inactivating Fas ligand expression. [PDF]

Bioengineered, 2021
Li Z, Sun C, Chen M, Wang B.
europepmc   +1 more source